Table 1.
Baseline characteristics
| Clinical characteristic | Value |
|---|---|
| Age (years) | 59.7±10.3 |
| Sex | |
| Male | 26 (86.67) |
| Etiology | |
| HBV | 21 (70.0) |
| HCV | 3 (10.0) |
| Alcohol | 6 (20.0) |
| NAFLD | 0 (0.0) |
| Albumin (g/dL) | 3.83±0.54 |
| Total bilirubin (mg/dL) | 1.0±0.58 |
| Prothrombin time (INR) | 1.11±0.14 |
| Platelets (×103/L) | 148.5±66.3 |
| Child-Pugh class | |
| A | 25 (83.3) |
| B | 5 (16.7) |
| Log(AFP) (ng/mL) | 2.44±1.25 |
| Log(PIVKA-II) (mAU/mL) | 2.85±1.18 |
| Total sum of diameters of viable lesions (cm) | 7.1±3.4 |
| Number of nodules | 1.60±0.62 |
| Type of HCC | |
| Nodular | 14 (46.7) |
| Diffuse or infiltrative | 16 (53.3) |
| Level of PVI | |
| Vp1–Vp3 | 15 (50.0) |
| Vp4 | 15 (50.0) |
| Tumor extent | |
| Unilobar | 12 (40.0) |
| Bilobar | 18 (60.0) |
| Extrahepatic metastasis | |
| None | 29 (96.7) |
| Yes | 1 (3.3) |
Values are presented as mean±standard deviation or number (%).
HBV, hepatitis B virus; HCV, hepatitis C virus; NAFLD, nonalcoholic fatty liver disease; AFP, alpha-fetoprotein; PIVKA-II, prothrombin induced by vitamin K absence-II; HCC, hepatocellular carcinoma; PVI, portal vein invasion.
*
by Pearson chi-squared test;
†
by Fisher’s exact test;
§
by student’s t-test or Mann-Whitney test.